QUAL - iShares Edge MSCI USA Quality Factor ETF

BATS - BATS Delayed Price. Currency in USD
-0.30 (-0.35%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close86.23
Bid85.93 x 100
Ask89.36 x 100
Day's Range85.67 - 86.87
52 Week Range69.33 - 86.87
Avg. Volume252,685
Net Assets4.37B
PE Ratio (TTM)N/A
YTD Return22.27%
Beta (3y)0.94
Expense Ratio (net)0.15%
Inception Date2013-07-16
  • ETF Trends3 months ago

    Smart Beta Investing: Right Time to Confirm Quality

    Quality stocks are working this year. Confirmation of that notion comes by way of the iShares Edge MSCI USA Quality Factor ETF (BATS: QUAL), which is up 15% year-to-date and currently residing near record ...

  • Quality ETF (QUAL) Hits New 52-Week High
    Zacks4 months ago

    Quality ETF (QUAL) Hits New 52-Week High

    This quality ETF hits a new 52-week high. Are more gains in store for this ETF?

  • Growth, Momentum ETFs Gain Ground
    ETF.com4 months ago

    Growth, Momentum ETFs Gain Ground

    When it comes to single-factor investing, growth and momentum ETFs have performed very well this year, and have attracted significant assets along the way. The lineup of growth and momentum ETFs, however, couldn’t be more different, making choosing a fund to ride the wave potentially tricky. From a performance perspective, both growth and momentum are benefiting from a slow-and-steady economy, according to Russ Koesterich, portfolio manager for BlackRock’s Global Allocation team.

  • 5 Quality ETFs and Stocks for Outperformance
    Zacks5 months ago

    5 Quality ETFs and Stocks for Outperformance

    Quality stocks reduce volatility when compared to plain vanilla products and hold up rather well during market swings.

  • Zacks5 months ago

    Will Tobacco Troubles Really Char Staples ETFs' Safety?

    FDA intends to reduce nicotine levels in cigarettes to non-addictive. Will these hurt consumer staples ETFs at all?

  • 3 Sector Gainers And Losers; 2 Equity Plays Near Buy Zone
    Investor's Business Daily5 months ago

    3 Sector Gainers And Losers; 2 Equity Plays Near Buy Zone

    Two U.S. equity funds may set up a buy opportunity on a pullback to the 50-day moving average.

  • Kiplinger6 months ago

    5 Super Low-Cost ETFs

    Our choices aim to beat traditional benchmarks.

  • Market Realist6 months ago

    Biogen’s Biosimilars Witnessed High Growth in 2Q17

    In 2Q17, Biogen’s (BIIB) biosimilars franchise reported revenue of ~$91 million, compared to $31 million in 2Q16.

  • Morningstar6 months ago

    Quality and Value Without the Side Sector Bets

    Quality and value investment strategies often introduce ancillary sector bets, but it may be prudent to constrain them.

  • ETF.com7 months ago

    Nearly $250B Inflows So Far In 2017

    So much for the summer doldrums. Prices for U.S. stocks and flows into U.S.-listed ETFs showed no signs of exhaustion, as both raced to records in June. In total, $45.5 billion of new money entered ETFs during the month, while the S&P 500 rallied to as high as 2,454. With six months of the year in the books, investors have added a whopping $249.4 billion into ETFs in 2017, not far from the $287.5 billion they added to ETFs during the entirety of 2016.

  • Business Wire7 months ago

    BlackRock to Transition Primary Listing Venue for 50 iShares ETFs

    BlackRock will transition the primary listing venue for 50 iShares ETFs.

  • Miss Thursday's Breakouts? 2 Fresh Ideas As Market Hits Highs
    Investor's Business Daily8 months ago

    Miss Thursday's Breakouts? 2 Fresh Ideas As Market Hits Highs

    Here are two investment ideas for those seeking to capture the Dow Jones industrial average's performance as the index reaches new highs.

  • Smart Beta ETFs Tilt Target Date Funds
    ETF.com8 months ago

    Smart Beta ETFs Tilt Target Date Funds

    Todd Rosenbluth is director of ETF and mutual fund research at CFRA. Asset managers have been advocating the usage of index-based products focused on minimum volatility, quality, momentum and other factors in recent years, suggesting that these were better ingredients for portfolio construction. In recent months, some of them have taken the logical next step and put these smart-beta products to use in their own kitchens.

  • Market Realist9 months ago

    How Kimberly-Clark’s Segments Performed in 1Q17

    Kimberly-Clark’s (KMB) personal care segment rose 2.0% in 1Q17, driven by increased volumes and a currency tailwind.

  • Morningstar10 months ago

    Are Factor Investors Getting Paid to Take on Industry Risk?

    Industry tilts appear to pay off for momentum but are not integral to the success of value and low-volatility strategies.

  • Morningstar11 months ago

    Mind the Gap Between Academic Research and Practice

    The returns of factor investment strategies often look more impressive in academia than in practice.

  • Market Realistlast year

    CLSA Rated Lululemon Athletica as ‘Underperform’

    Lululemon Athletica (LULU) has a market cap of $9.3 billion. It fell 2.2% to close at $66.99 per share on January 19, 2017.